Business Context and Reporting Period
This Form 8-K is a current report filed by U.S. Physical Therapy, Inc. (USPH) on September 15, 2026. The filing discloses a corporate governance event regarding the appointment of a new member to the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the appointment of Ms. Myra Davis to the Board of Directors, effective October 1, 2026. Ms. Davis brings over two decades of CIO-level healthcare leadership experience, most recently serving as Executive Vice President and Chief Information Innovation Officer at Texas Children's Hospital.
Guidance, Outlook, and Management Commentary
- Compensation: Upon joining, Ms. Davis will receive an annual cash retainer and annual equity grant. Specific amounts are not disclosed in this filing but will be determined in accordance with the "Director Compensation" section of the Company's definitive proxy statement filed on April 16, 2026.
- Committee Assignments: As of the filing date, Ms. Davis has not been appointed to any Board committees.
- Related Parties: The filing states there are no reportable related-party transactions between Ms. Davis and the Company.
Key Facts for Investor Verification
- Verify the specific compensation amounts for Ms. Davis in the definitive proxy statement filed on April 16, 2026.
- Confirm the effective date of the appointment (October 1, 2026) and any subsequent committee assignments.
- Review the press release dated September 21, 2026 (Exhibit 99.1) for additional context on the appointment.